MCM

M28 Capital Management Portfolio holdings

AUM $58.6M
1-Year Est. Return 32.71%
This Quarter Est. Return
1 Year Est. Return
+32.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$58.6M
AUM Growth
-$14.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$4.19M
2
+$2.44M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.24B
$36.8M 62.8%
5,664,548
IVVD icon
2
Invivyd
IVVD
$373M
$6.61M 11.28%
9,248,250
TGTX icon
3
TG Therapeutics
TGTX
$5.5B
$5.82M 9.92%
161,600
GUTS icon
4
Fractyl Health
GUTS
$171M
$3.01M 5.13%
1,856,117
PRQR icon
5
ProQR Therapeutics
PRQR
$293M
$2.08M 3.55%
1,019,498
CRIS icon
6
Curis
CRIS
$19.2M
$1.21M 2.06%
521,059
SLN
7
Silence Therapeutics
SLN
$307M
$1.07M 1.83%
185,100
ARWR icon
8
Arrowhead Research
ARWR
$5.09B
$1.06M 1.82%
67,400
RCKT icon
9
Rocket Pharmaceuticals
RCKT
$400M
$945K 1.61%
385,680
BBIO icon
10
BridgeBio Pharma
BBIO
$10.5B
– –
-121,200
SWTX
11
DELISTED
SpringWorks Therapeutics
SWTX
– –
-55,200